Loading company…
Wuhan Youngsen Biotech develops and manufactures artificial blood vessel products.
Founded in 2009 and based in Wuhan, China, Wuhan Youngsen Biotech develops artificial blood vessels, including the VASCULAR GRAFT and a triple-layer bionic small-caliber model. Its YSVG-S02 program began clinical trials in June 2020. In February 2015, it raised CNY 20 million in Series A funding from Shenzhen Capital Group.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in